Pfizer aims for wider use of PARP drug in prostate cancer with new data
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Pfizer is seeking to expand the use of a parp drug in treating prostate cancer. The company has presented new data in support of this effort. The new data may facilitate a broader application of the drug in prostate cancer treatment.